Skip to main content

DNA sequencing giant Illumina just bought rival Pac Bio for $1.2 billion — here's why

Illumina made a move that will help it retain its dominance in the burgeoning DNA-sequencing field, experts say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.